ISDA

Deposition Date 2010-09-14

Release Date 2010-12-01

Last Version Date 2024-10-30

Entry Detail

PDB ID:

3OUI

Keywords:

OXIDOREDUCTASE

Title:

PHD2-R717 with 40787422

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

ESCHERICHIA COLI

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.70 Å

R-Value Free:

0.21

R-Value Work:

0.18

R-Value Observed:

0.19

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Egl nine homolog 1
Gene (Uniprot):EGLN1
Chain IDs:A
Chain Length:213
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q9GZT9 Pfam ID:PF13640 EC:1.14.11.2

Ligand Molecules

42Z

ACT

FE2

PEG

Primary Citation

Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues.

Rosen, M.D, Venkatesan, H, Peltier, H.M, Bembenek, S.D, Kanelakis, K.C, Zhao, L.X, Leonard, B.E, Hocutt, F.M, Wu, X, Palomino, H.L, Brondstetter, T.I, Haugh, P.V, Cagnon, L, Yan, W, Liotta, L.A, Young, A, Mirzadegan, T, Shankley, N.P, Barrett, T.D, Rabinowitz, M.H.Show

ACS Med Chem Lett 1 526 529 (2010)

PMID: 24900242 DOI: 10.1021/ml100198y

Abstact

HIF prolyl 4-hydroxylases (PHD) are a family of enzymes that mediate key physiological responses to hypoxia by modulating the levels of hypoxia inducible factor 1-α (HIF1α). Certain benzimidazole-2-pyrazole carboxylates were discovered to be PHD2 inhibitors using ligand- and structure-based methods and found to be potent, orally efficacious stimulators of erythropoietin secretion in vivo.

Legend

Protein

Chemical

Disease

Primary Citation of related structures